Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, 11562 Kasr El-Eini, Cairo, Egypt.
Eur J Med Chem. 2012 Jul;53:141-9. doi: 10.1016/j.ejmech.2012.03.050. Epub 2012 Apr 9.
Two groups of hybrid compounds: the quinazolinone-dihydropyrimidines and quinazolinone-pyrimidines, were synthesized. The starting derivative 3 was reacted with chloroacetyl chloride to give intermediate 5 which was condensed with the 2-mercaptopyrimidines 4a-c affording compounds 6a-c. These latter compounds underwent hydrolysis and N-alkylation reactions to give the dihydropyrimidine derivatives 7a-c and 8a-f, respectively. The chloro derivatives 9a-c subsequently reacted with various anilines furnishing compounds 10a-i. The anti-inflammatory activity of the synthesized compounds were evaluated using the carrageenan-induced rat paw oedema model and ulcer indices for the most active compounds were calculated. Five compounds were found more active and less ulcerogenic than diclofenac particularly compound 10 g (IC(50) = 116.73 μmol/kg; ulcer index = 11.38). Compound 10 g was also 2-fold more selective inhibitor of COX-2 than COX-1.
喹唑啉酮-二氢嘧啶和喹唑啉酮-嘧啶。起始衍生物 3 与氯乙酰氯反应生成中间体 5,5 与 2-巯基嘧啶 4a-c 缩合得到化合物 6a-c。这些化合物进一步经历水解和 N-烷基化反应,分别得到二氢嘧啶衍生物 7a-c 和 8a-f。随后,氯代衍生物 9a-c 与各种苯胺反应生成化合物 10a-i。用角叉菜胶诱导的大鼠足肿胀模型评估了合成化合物的抗炎活性,并计算了最活跃化合物的溃疡指数。有 5 种化合物比双氯芬酸更有效且致溃疡作用更小,特别是化合物 10g(IC50=116.73μmol/kg;溃疡指数=11.38)。化合物 10g 对 COX-2 的选择性抑制作用也比 COX-1 强 2 倍。